At the time of writing, ORIC Pharmaceuticals Inc [ORIC] stock is trading at $10.9, up 4.51%. An important factor to consider is whether the stock is rising or falling in short-term value. The ORIC shares have gain 7.50% over the last week, with a monthly amount glided 16.95%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ORIC Pharmaceuticals Inc [NASDAQ: ORIC] stock has seen the most recent analyst activity on July 08, 2025, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $15. Previously, Wells Fargo started tracking the stock with Overweight rating on October 31, 2024, and set its price target to $20. On September 06, 2024, Stifel initiated with a Buy rating and assigned a price target of $20 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating. Wedbush initiated its recommendation with a Outperform and recommended $8 as its price target on September 22, 2023. H.C. Wainwright upgraded its rating to Buy for this stock on March 23, 2023, but kept the price target unchanged to $16. In a note dated March 21, 2023, Guggenheim upgraded an Buy rating on this stock but restated the target price of $15.
For the past year, the stock price of ORIC Pharmaceuticals Inc fluctuated between $3.90 and $14.67. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. ORIC Pharmaceuticals Inc [NASDAQ: ORIC] shares were valued at $10.9 at the most recent close of the market. An investor can expect a potential return of 10.09% based on the average ORIC price forecast.
Analyzing the ORIC fundamentals
Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at -275.09%, Pretax Profit Margin comes in at -249.26%, and Net Profit Margin reading is -249.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.55, Equity is -0.51 and Total Capital is -0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.57 points at the first support level, and at 10.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.19, and for the 2nd resistance point, it is at 11.48.
Ratios To Look Out For
It is important to note that ORIC Pharmaceuticals Inc [NASDAQ:ORIC] has a current ratio of 12.00. On the other hand, the Quick Ratio is 12.00, and the Cash Ratio is 2.8.
Transactions by insiders
Recent insider trading involved Piscitelli Dominic, Chief Financial Officer, that happened on Jul 01 ’25 when 20000.0 shares were sold. Chief Financial Officer, Piscitelli Dominic completed a deal on Jun 24 ’25 to sell 32466.0 shares. Meanwhile, Chief Financial Officer Piscitelli Dominic sold 1034.0 shares on Jun 23 ’25.
